These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
198 related articles for article (PubMed ID: 31431822)
41. The role of the digital rectal examination as diagnostic test for prostate cancer detection in obese patients. Dell'Atti L J BUON; 2015; 20(6):1601-5. PubMed ID: 26854458 [TBL] [Abstract][Full Text] [Related]
42. The role of the digital rectal examination in subsequent screening visits in the European randomized study of screening for prostate cancer (ERSPC), Rotterdam. Gosselaar C; Roobol MJ; Roemeling S; Schröder FH Eur Urol; 2008 Sep; 54(3):581-8. PubMed ID: 18423977 [TBL] [Abstract][Full Text] [Related]
43. Complete response with early introduction of cabazitaxel in a patient with multiple lung metastases of castration-resistant prostate cancer following the early detection of metastases using liquid biopsy: a case report. Kosaka T; Hongo H; Oya M BMC Cancer; 2019 Jun; 19(1):562. PubMed ID: 31185946 [TBL] [Abstract][Full Text] [Related]
44. Extended use of Prostate Health Index and percentage of [-2]pro-prostate-specific antigen in Chinese men with prostate specific antigen 10-20 ng/mL and normal digital rectal examination. Chiu PK; Teoh JY; Lee WM; Yee CH; Chan ES; Hou SM; Ng CF Investig Clin Urol; 2016 Sep; 57(5):336-42. PubMed ID: 27617315 [TBL] [Abstract][Full Text] [Related]
45. Prostate cancer in patients with an abnormal digital rectal examination and serum prostate-specific antigen less than 4.0 ng/mL. Bozeman CB; Carver BS; Caldito G; Venable DD; Eastham JA Urology; 2005 Oct; 66(4):803-7. PubMed ID: 16230142 [TBL] [Abstract][Full Text] [Related]
46. Obesity and oncological outcome after radical prostatectomy: impact of prostate-specific antigen-based prostate cancer screening: results from the Shared Equal Access Regional Cancer Hospital and Duke Prostate Center databases. Freedland SJ; Sun L; Kane CJ; Presti JC; Terris MK; Amling CL; Moul JW; Aronson WJ BJU Int; 2008 Sep; 102(8):969-74. PubMed ID: 18691175 [TBL] [Abstract][Full Text] [Related]
47. Screening for prostate cancer at low PSA range: the impact of digital rectal examination on tumor incidence and tumor characteristics. Gosselaar C; Roobol MJ; Roemeling S; van der Kwast TH; Schröder FH Prostate; 2007 Feb; 67(2):154-61. PubMed ID: 17044079 [TBL] [Abstract][Full Text] [Related]
48. Early detection of prostate cancer in Germany: a study using digital rectal examination and 4.0 ng/ml prostate-specific antigen as cutoff. Luboldt HJ; Bex A; Swoboda A; Hüsing J; Rübben H; Eur Urol; 2001 Feb; 39(2):131-7. PubMed ID: 11223671 [TBL] [Abstract][Full Text] [Related]
49. Early outcomes of active surveillance for localized prostate cancer. Hardie C; Parker C; Norman A; Eeles R; Horwich A; Huddart R; Dearnaley D BJU Int; 2005 May; 95(7):956-60. PubMed ID: 15839912 [TBL] [Abstract][Full Text] [Related]
50. Digital rectal examination is no longer necessary in the routine follow-up of men with undetectable prostate specific antigen after radical prostatectomy: the implications for follow-up. Chaplin BJ; Wildhagen MF; Schroder FH; Kirkels WJ; Bangma CH Eur Urol; 2005 Dec; 48(6):906-10. PubMed ID: 16126322 [TBL] [Abstract][Full Text] [Related]
51. Risk factors for bone loss with prostate cancer in Korean men not receiving androgen deprivation therapy. Kim SO; Kang TW; Kwon D; Park K; Ryu SB Int Braz J Urol; 2009; 35(2):183-8; discussion 189. PubMed ID: 19409122 [TBL] [Abstract][Full Text] [Related]
52. Operating characteristics of prostate-specific antigen in men with an initial PSA level of 3.0 ng/ml or lower. Thompson IM; Ankerst DP; Chi C; Lucia MS; Goodman PJ; Crowley JJ; Parnes HL; Coltman CA JAMA; 2005 Jul; 294(1):66-70. PubMed ID: 15998892 [TBL] [Abstract][Full Text] [Related]
53. Characteristics of prostate cancer detected by digital rectal examination only. Okotie OT; Roehl KA; Han M; Loeb S; Gashti SN; Catalona WJ Urology; 2007 Dec; 70(6):1117-20. PubMed ID: 18158030 [TBL] [Abstract][Full Text] [Related]
54. Androgen-deprivation therapy in the management of neuroendocrine prostate cancer. Martínez-Cornelio A; González-Pérez J; Tabares-García Fde J; Ramos-Salgado F; Alvarado-Cabrero I; Hernández-Toriz N Cir Cir; 2009; 77(4):293-9; 273-8. PubMed ID: 19919791 [TBL] [Abstract][Full Text] [Related]
55. Early diagnosis of prostate cancer in the Western Cape. Heyns CF; Naudé AM; Visser AJ; Marais DC; Stopforth HB; Nyarko JK; Stellmacher GA S Afr Med J; 2001 Aug; 91(8):679-84. PubMed ID: 11584784 [TBL] [Abstract][Full Text] [Related]
56. Extended lymphadenectomy for high-risk prostate cancer in patients with chronic lymphocytic leukemia may not be necessary: a report of two cases. Zhu Y; Wang Y; Qian Z; Pan J; Liu Q; Dong B; Xue W BMC Cancer; 2019 Jul; 19(1):676. PubMed ID: 31288785 [TBL] [Abstract][Full Text] [Related]
57. Radical prostatectomy and adjuvant endocrine therapy for prostate cancer with or without preoperative androgen deprivation: Five-year results. Homma Y; Akaza H; Okada K; Yokoyama M; Moriyama N; Usami M; Hirao Y; Tsushima T; Sakamoto A; Ohashi Y; Aso Y; Int J Urol; 2004 May; 11(5):295-303. PubMed ID: 15147545 [TBL] [Abstract][Full Text] [Related]
58. Finasteride improves the sensitivity of digital rectal examination for prostate cancer detection. Thompson IM; Tangen CM; Goodman PJ; Lucia MS; Parnes HL; Lippman SM; Coltman CA J Urol; 2007 May; 177(5):1749-52. PubMed ID: 17437804 [TBL] [Abstract][Full Text] [Related]
59. Analysis of the local control in lymph-node staged localized prostate cancer treated by external beam radiotherapy, assessed by digital rectal examination, serum prostate-specific antigen and biopsy. Borghede G; Aldenborg F; Wurzinger E; Johansson KA; Hedelin H Br J Urol; 1997 Aug; 80(2):247-55. PubMed ID: 9284197 [TBL] [Abstract][Full Text] [Related]